Abstract:Abstract Background Epigenetic clocks use DNA methylation (DNAm) levels of specific sets of CpG dinucleotides to accurately predict individual chronological age. A popular application of these clocks is to explore whether the deviation of predicted age from chronological age is associated with disease phenotypes, where this deviation is interpreted as a potential biomarker of biological age. This wide application, however, contrasts with the limited insight in the processes that may drive the running of epigenetic clocks. Results We perform a functional genomics analysis on four epigenetic clocks, including Hannum’s blood predictor and Horvath’s multi-tissue predictor, using blood DNA methylome and transcriptome data from 3132 individuals. The four clocks result in similar predictions of individual chronological age, and their constituting CpGs are correlated in DNAm level and are enriched for similar histone modifications and chromatin states. Interestingly, DNAm levels of CpGs from the clocks are commonly associated with gene expression in trans . The gene sets involved are highly overlapping and enriched for T cell processes. Further analysis of the transcriptome and methylome of sorted blood cell types identifies differences in DNAm between naive and activated T and NK cells as a probable contributor to the clocks. Indeed, within the same donor, the four epigenetic clocks predict naive cells to be up to 40 years younger than activated cells. Conclusions The ability of epigenetic clocks to predict chronological age involves their ability to detect changes in proportions of naive and activated immune blood cells, an established feature of immuno-senescence. This finding may contribute to the interpretation of associations between clock-derived measures and age-related health outcomes.

Functional genomics analysis identifies T and NK cell activation as a driver of epigenetic clock progression

Comparative analysis of epigenetic aging clocks from CpG characteristics to functional associations

Development of an epigenetic clock resistant to changes in immune cell composition

A Targeted Epigenetic Clock for the Prediction of Biological Age

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution

A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking

What makes clocks tick? Characterizing developmental dynamics of adult epigenetic clock sites

Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

DNA methylation aging clocks: challenges and recommendations

Dissecting the impact of differentiation stage, replicative history, and cell type composition on epigenetic clocks

Underlying features of epigenetic aging clocks in vivo and in vitro

DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan

Refining epigenetic prediction of chronological and biological age

Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1

Quantifying the Stochastic Component of Epigenetic Aging

Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation

EPIGENETIC PREDICTORS OF LIFESPAN AND HEALTHSPAN

A Novel Blood-Based Epigenetic Clock for Intrinsic Capacity Predicts Mortality and is Associated with Clinical, Immunological and Lifestyle Factors

Epigenetic clock: A promising biomarker and practical tool in aging

Probabilistic inference of epigenetic age acceleration from cellular dynamics